lasix - risultati della ricerca

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tamsulosin t-mepha retard retardtabletten

mepha pharma ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.376 mg, hypromellosum, cellulosum microcristallinum, carbomerum, silica colloidalis anhydrica, magnesii stearas, e 172 (rubrum), pro compresso. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tamsulosin t spirig hc retardtabletten

spirig healthcare ag - tamsulosini hydrochloridum - retardtabletten - tamsulosini hydrochloridum 0,4 mg, excipiens pro compresso. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tamsulosin retard zentiva 0.4 mg retardkapseln

helvepharm ag - tamsulosini hydrochloridum - retardkapseln - tamsulosini hydrochloridum 0,4 mg, colore.: e 132, excipiens pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dutasterid tamsulosin sandoz eco 0.5 mg/ 0.4 mg capsule

sandoz pharmaceuticals ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: glyceroli monocaprylocapras, e 321, gelatina, glycerolum 64.2 mg, aqua purificata, e 171, e 172 (flavum), triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: cellulosum microcristallinum, magnesii stearas, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum corresp. natrium 0.05 mg, triacetinum, e 171, talcum, kapselhülle: hypromellosum, kalii chloridum, carrageenanum, e 171, e 110 0.06 mg, e 172 (rubrum), aqua purificata, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dutasterid-tamsulosin xiromed 0,5 mg/0,4 mg capsule rigide

xiromed sa - dutasteridum, tamsulosini hydrochloridum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, e 171, glycerolum, triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika